Exane Derivatives’s CDK Global, Inc. CDK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
$1.42K Hold
26
﹤0.01% 469
2022
Q1
$1.27K Hold
26
﹤0.01% 788
2021
Q4
$1.08K Hold
26
﹤0.01% 701
2021
Q3
$1.11K Hold
26
﹤0.01% 853
2021
Q2
$1.28K Hold
26
﹤0.01% 853
2021
Q1
$1.41K Hold
26
﹤0.01% 708
2020
Q4
$1.35K Hold
26
﹤0.01% 657
2020
Q3
$1.13K Hold
26
﹤0.01% 608
2020
Q2
$1.08K Hold
26
﹤0.01% 550
2020
Q1
$854 Hold
26
﹤0.01% 551
2019
Q4
$1.46K Hold
26
﹤0.01% 521
2019
Q3
$1.25K Hold
26
﹤0.01% 525
2019
Q2
$1.28K Hold
26
﹤0.01% 545
2019
Q1
$1.53K Hold
26
﹤0.01% 469
2018
Q4
$1.24K Buy
+26
New +$1.37K ﹤0.01% 559
2016
Q4
Sell
-47
Closed -$2.7K 690
2016
Q3
$2.7K Hold
47
﹤0.01% 459
2016
Q2
$2.61K Hold
47
﹤0.01% 403
2016
Q1
$2.19K Buy
+47
New +$2.09K ﹤0.01% 457
2015
Q4
Sell
-47
Closed -$2.25K 575
2015
Q3
$2.25K Buy
+47
New +$2.38K ﹤0.01% 396

Other funds holding CDK

Exane Derivatives's CDK Position: Q2 2022 in Review

Exane Derivatives held its CDK Global, Inc. (CDK) position steady in Q2 2022 at 26 shares worth $1.42K. The position accounts for ﹤0.01% of the portfolio, ranked #469.

Exane Derivatives first reported a position in CDK in Q3 2015 and has held it in 19 quarters since. The position peaked at $2.7K in Q3 2016. 455 funds tracked by Wall St. Rank hold CDK as of Q2 2022.

  • Exane Derivatives held 26 shares of CDK Global, Inc. worth $1.42K as of Q2 2022.
  • Exane Derivatives left its CDK Global, Inc. share count unchanged in Q2 2022.
  • CDK Global, Inc. made up ﹤0.01% of Exane Derivatives's portfolio in Q2 2022, its #469 holding.
  • Exane Derivatives first reported a position in CDK Global, Inc. in Q3 2015 and has held it in 19 quarters since.
  • Exane Derivatives's CDK Global, Inc. position peaked at $2.7K in Q3 2016.
  • 455 funds tracked by Wall St. Rank held CDK Global, Inc. as of Q2 2022.

Based on Exane Derivatives's 13F filing for Q2 2022, filed 12 Jul 2022.